RadioMedix

Develops targeted radiopharmaceuticals for cancer diagnosis and treatment

Founded 2006 · 40 employees · United States · Private

Funding:

Series A · $40M · 2022

Subsidiaries:

Detectnet, AlphaMedix, GlucoMedix, OncoMedix, SmartMedix